Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.
van Oers MH, Tönnissen E, Van Glabbeke M, Giurgea L, Jansen JH, Klasa R, Marcus RE, Wolf M, Kimby E, Vranovsky A, Holte H, Hagenbeek A, van der Reijden BA. van Oers MH, et al. Among authors: tonnissen e. J Clin Oncol. 2010 May 1;28(13):2246-52. doi: 10.1200/JCO.2009.25.0852. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368567 Clinical Trial.
Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer.
Noordermeer SM, Wennemers M, Bergevoet SM, van der Heijden A, Tönnissen E, Sweep FC, Jansen JH, Span PN, van der Reijden BA. Noordermeer SM, et al. Among authors: tonnissen e. Breast Cancer Res Treat. 2012 Aug;135(1):125-33. doi: 10.1007/s10549-012-2122-5. Epub 2012 Jun 16. Breast Cancer Res Treat. 2012. PMID: 22706632 Free PMC article.
Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial.
Aslanyan MG, Kroeze LI, Langemeijer SM, Koorenhof-Scheele TN, Massop M, van Hoogen P, Stevens-Linders E, van de Locht LT, Tönnissen E, van der Heijden A, da Silva-Coelho P, Cilloni D, Saglio G, Marie JP, Tang R, Labar B, Amadori S, Muus P, Willemze R, Marijt EW, de Witte T, van der Reijden BA, Suciu S, Jansen JH. Aslanyan MG, et al. Among authors: tonnissen e. Ann Hematol. 2014 Aug;93(8):1401-12. doi: 10.1007/s00277-014-2055-7. Epub 2014 Mar 29. Ann Hematol. 2014. PMID: 24994606
Characterization of a genomic region 8 kb downstream of GFI1B associated with myeloproliferative neoplasms.
van Bergen MGJM, van Oorschot R, Bergevoet SM, de Graaf AO, Tönnissen ELRTM, Stevens-Linders E, Neveling K, Jansen PWTC, Baltissen MPA, Vermeulen M, Mandoli A, Martens JHA, Preijers F, Jansen JH, van der Reijden BA. van Bergen MGJM, et al. Among authors: tonnissen elrtm. Biochim Biophys Acta Mol Basis Dis. 2021 Dec 1;1867(12):166259. doi: 10.1016/j.bbadis.2021.166259. Epub 2021 Aug 31. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 34450246 Free article.
Rapid identification of IDH1 and IDH2 mutations in acute myeloid leukaemia using high resolution melting curve analysis.
Noordermeer SM, Tönnissen E, Vissers I, van der Heijden A, van de Locht LT, Deutz-Terlouw PP, Marijt EW, Jansen JH, van der Reijden BA. Noordermeer SM, et al. Among authors: tonnissen e. Br J Haematol. 2011 Feb;152(4):493-6. doi: 10.1111/j.1365-2141.2010.08423.x. Epub 2010 Oct 19. Br J Haematol. 2011. PMID: 20955413 Free article. No abstract available.
Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma.
Mandigers CM, Meijerink JP, Mensink EJ, Tönnissen EL, Hebeda KM, Bogman MJ, Raemaekers JM; Interzol (South-East Netherlands Comprehensive Cancer Centers Cooperative Group). Mandigers CM, et al. Among authors: tonnissen el. Blood. 2001 Aug 15;98(4):940-4. doi: 10.1182/blood.v98.4.940. Blood. 2001. PMID: 11493436 Free article.
12 results